| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
69,985 |
60,552 |
$3.11M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
34,607 |
29,706 |
$1.62M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,312 |
17,971 |
$1.38M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,533 |
14,727 |
$1.28M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
16,002 |
14,138 |
$1.14M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
10,466 |
9,104 |
$799K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
34,861 |
30,629 |
$766K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,516 |
6,791 |
$509K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,193 |
4,217 |
$422K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,390 |
6,827 |
$354K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
7,595 |
6,678 |
$204K |
| 96127 |
|
29,483 |
24,543 |
$139K |
| 96160 |
|
10,545 |
8,489 |
$116K |
| 99381 |
|
1,344 |
1,128 |
$105K |
| 92551 |
|
13,450 |
11,418 |
$100K |
| 99215 |
Prolong outpt/office vis |
900 |
801 |
$84K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,779 |
1,626 |
$58K |
| 96161 |
|
6,223 |
5,384 |
$57K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,717 |
2,103 |
$52K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,222 |
3,798 |
$48K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,493 |
1,292 |
$44K |
| 3008F |
|
32,944 |
28,273 |
$43K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,851 |
2,605 |
$39K |
| 99383 |
|
481 |
411 |
$39K |
| 99173 |
|
7,690 |
6,472 |
$35K |
| 83655 |
|
3,271 |
2,933 |
$34K |
| 99460 |
|
617 |
532 |
$33K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
539 |
456 |
$28K |
| 85018 |
|
11,416 |
9,789 |
$23K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
82 |
63 |
$23K |
| 36416 |
|
14,253 |
11,923 |
$16K |
| 90670 |
|
9,649 |
8,454 |
$14K |
| 99177 |
|
2,115 |
1,925 |
$13K |
| 99382 |
|
155 |
119 |
$12K |
| 90461 |
|
22,251 |
19,368 |
$11K |
| 54150 |
|
66 |
52 |
$10K |
| 90651 |
|
1,519 |
1,186 |
$9K |
| 90698 |
|
12,515 |
11,054 |
$8K |
| 90677 |
|
2,752 |
2,499 |
$5K |
| 95117 |
|
326 |
107 |
$5K |
| 90686 |
|
6,616 |
5,865 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
55 |
43 |
$4K |
| 90680 |
|
7,660 |
6,797 |
$4K |
| 87807 |
|
400 |
357 |
$3K |
| 87634 |
|
74 |
63 |
$3K |
| 99384 |
|
24 |
24 |
$3K |
| 99462 |
|
84 |
65 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
154 |
117 |
$2K |
| 96380 |
|
123 |
101 |
$2K |
| 99051 |
|
602 |
555 |
$2K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
16 |
14 |
$2K |
| 90710 |
|
403 |
335 |
$2K |
| 95115 |
|
202 |
66 |
$2K |
| 90674 |
|
519 |
432 |
$2K |
| 82465 |
|
1,172 |
842 |
$2K |
| 90734 |
|
856 |
654 |
$2K |
| 90633 |
|
5,129 |
4,451 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
104 |
79 |
$1K |
| 99417 |
Prolong home eval add 15m |
40 |
28 |
$1K |
| 69210 |
|
45 |
26 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
93 |
46 |
$996.67 |
| 90744 |
|
5,447 |
4,789 |
$848.60 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
66 |
63 |
$762.45 |
| 0071A |
|
15 |
15 |
$600.00 |
| 90716 |
|
951 |
814 |
$600.00 |
| 90696 |
|
419 |
353 |
$594.09 |
| 90380 |
|
28 |
25 |
$571.73 |
| 81003 |
|
288 |
240 |
$545.92 |
| 90619 |
|
424 |
343 |
$525.00 |
| 99050 |
|
33 |
33 |
$508.81 |
| 0072A |
|
12 |
12 |
$480.00 |
| 94664 |
|
33 |
28 |
$421.39 |
| 90707 |
|
935 |
812 |
$378.40 |
| 99401 |
|
19 |
14 |
$361.14 |
| 90715 |
|
287 |
222 |
$175.93 |
| 90656 |
|
385 |
378 |
$147.95 |
| 92558 |
|
35 |
30 |
$118.83 |
| 94760 |
|
72 |
64 |
$46.80 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
95 |
80 |
$31.67 |
| 99000 |
|
2,570 |
2,353 |
$9.13 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
94 |
78 |
$9.05 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
12 |
12 |
$0.92 |
| 90621 |
|
103 |
57 |
$0.00 |
| 90685 |
|
310 |
288 |
$0.00 |
| 90661 |
|
306 |
263 |
$0.00 |
| 5250F |
|
16 |
13 |
$0.00 |
| 90381 |
|
49 |
42 |
$0.00 |
| 91307 |
|
76 |
54 |
$0.00 |
| 91305 |
|
13 |
13 |
$0.00 |